Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma.

Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma. Pediatr Blood Cancer. 2020 05; 67(5):e28153.

View in: PubMed